We have identified a new function for the dynein adaptor Bicaudal D homolog 1 (BICD1) by screening a siRNA library for genes affecting the dynamics of neurotrophin receptor-containing endosomes in motor neurons. Depleting BICD1 increased the intracellular accumulation of brain-derived neurotrophic factor (BDNF)-activated TrkB and p75
Introduction
Neurons have complex axonal and dendritic arborisations, which are paramount for the function of the nervous system. The development and maturation of these extended neuronal networks require tight regulation of the intracellular transport of organelles and cargoes, such as mRNA, mitochondria, growth factor receptors and their signalling adaptor molecules, which in turn are necessary to ensure neuronal growth, differentiation and survival (Ascano et al, 2012; Hirokawa et al, 2010; Salinas et al, 2008) .
Neurotrophins are essential for the development and maintenance of the nervous system (Ascano et al, 2012) . The neurotrophin family consists of four structurally related growth factors: nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), NT3 and NT4/5 (Bibel & Barde, 2000; Huang & Reichardt, 2001 ). These ligands bind and activate the tropomyosin-related kinases TrkA, TrkB and TrkC either alone or in combination with p75 neurotrophin receptor (p75 NTR ), which lacks enzymatic activity (Simi & Ibanez, 2010) . Neurotrophin receptors have different binding specificities for their ligands: TrkA binds preferentially to NGF; TrkB to BDNF and NT4/5; TrkC to NT-3, whilst p75 NTR can bind all four neurotrophins, including proneurotrophins (Teng et al, 2010) . The considerable crosstalk in the binding of neurotrophins to their receptors generates a variety of signalling outputs resulting in diverse cellular responses, which are initiated both by ligand availability and the relative abundance of each neurotrophin receptor at specific locations on the neuronal surface (Ascano et al, 2012; Reichardt, 2006) . This signalling diversity is further enhanced because the same neurotrophin can have opposing effects, depending on whether it is presented to the neuron as the precursor or mature form (Teng et al, 2010) . It is therefore important that neurotrophin signalling is tightly controlled both spatially and temporally, particularly in the developing nervous system when neurotrophins and their receptors are abundantly expressed.
The signalling cascades activated by neurotrophins in the neuronal periphery are regulated by the endocytosis, sorting and trafficking of neurotrophin receptors along the axon or dendrites towards the cell body, where they elicit transcriptional responses (Ascano et al, 2012; Ibanez, 2007; Schmieg et al, 2013) . We have previously shown that the binding fragment of tetanus neurotoxin (HCT) is a reliable probe to monitor neurotrophin receptor uptake and intracellular trafficking (Bercsenyi et al, 2013) .
Indeed, HCT and p75 NTR bound to NGF accumulate in clathrin-coated pits and are internalised by a clathrin-mediated endocytic pathway in motor neurons (Deinhardt et al, 2006a; Deinhardt et al, 2007) . Furthermore, HCT shares the same axonal retrograde transport organelles with neurotrophins and their receptors (Deinhardt et al, 2006b; Lalli & Schiavo, 2002) .
Since a comprehensive understanding of the molecular mechanisms controlling neurotrophin receptor internalisation and trafficking is still lacking, we sought to identify new genes involved in this pathway by performing an siRNA screen in motor neurons derived from transgenic HB9-GFP embryonic stem (ES) using HCT and an antibody directed against p75 NTR (αp75 NTR ) as fluorescent reporters (Terenzio et al, 2014) .
Importantly, expression of green fluorescent protein (GFP) driven by the Hb9 homeobox gene enhancer (Wichterle et al, 2002) facilitated the unequivocal identification of motor neurons generated from these cells upon differentiation (Terenzio et al, 2014) .
Using this approach, we identified a small cohort of genes affecting the intracellular accumulation of HCT and αp75 NTR when silenced (see Table S1 ). Knockdown of one gene in particular, bicaudal D homolog 1 (Bicd1) yielded an increased internalisation phenotype for HCT and was selected for further analyses, which demonstrated that BICD1 depletion also increased the intracellular accumulation of ligand-bound p75 NTR and TrkB (Terenzio et al, 2014) .
BICD1 is known to participate in endosomal trafficking and dynein-mediated processes (Aguirre-Chen et al, 2011; Bianco et al, 2010; Hoogenraad et al, 2001; Matanis et al, 2002) , including retrograde transport in neuronal cells (Wanschers et al, 2007) .
Furthermore, BICD1 has important roles in the development and function of the Drosophila and C. elegans nervous systems (Li et al, 2010) . We now show that BICD1
is a key regulator of the intracellular trafficking of neurotrophin receptors and that it performs this role by controlling the BDNF-triggered sorting and progression of p75 NTR and TrkB through the endosomal pathway. BICD1 depletion disrupted this mechanism to favour p75 NTR and TrkB recycling, which in turn affected their signalling.
Our data identify a novel function for BICD1 as a modulator of neurotrophin receptor dynamics and signalling, which may also be relevant for other receptor tyrosine kinases in different cellular systems.
Results

Bicd1 is strongly expressed in the developing central and peripheral nervous systems
One of the most prominent candidates from our siRNA screen was BICD1 (Terenzio et al, 2014) . Since BICD1 and related proteins are cytoplasmic dynein adaptors (Hoogenraad et al, 2001; Matanis et al, 2002) , and BICD1 has been postulated to function in retrograde transport (Wanschers et al, 2007) , we decided to focus our efforts on addressing the role played by BICD1 in the regulation of neurotrophin receptor trafficking in our model system.
We used a Bicd1 gene-trapped ES cell clone (Bicd1 gt/+ ; gene trap RRP227) for the functional characterisation of BICD1. This genetrap vector expressed a β-galactosidase cassette, allowing us to determine Bicd1 expression patterns in chimeric embryos generated from Bicd1 gt/+ ES cells ( Figure 1A ). X-gal histochemistry of 
S1A-C).
Altogether, these observations suggest that BICD1 plays a role in the developing nervous system at a time when neurotrophins and their receptors are highly expressed (Davies, 1994; Ernfors, 2001; Klein, 1994) .
However, only one developmental day later, the expression pattern of Bicd1 had dramatically changed: at E14.5 Bicd1-LacZ had been lost from the brain ( Figure S1E) and spinal cord ( Figure S1F ), yet was still strongly retained in DRG ( Figure S1F-G) and was most notably upregulated in skin, skeletal muscle and heart ventricles, but interestingly, not in the atria ( Figure S1H ). (Voss et al, 1998) . In contrast, Bicd2 mRNA levels were found to be approximately 80% higher in Bicd1 gt/gt motor neurons compared to wild type controls ( Figure S1D ), suggesting that BICD2 might compensate for the partial loss of BICD1. However, this scenario is unlikely since BICD2 protein levels were not increased in Bicd1 gt/gt motor neurons ( Figure S2A ).
Bicd1
BICD1 depletion had no significant effect on the expression of the motor neuron markers Hb9 and ChAT (choline acetyltransferase) (Figure S1D ), or p75 NTR ( Figure   1E -F and S1D), whilst Trk protein levels did exhibit an approximate 30% decrease using a pan-Trk antibody ( Figure 1F ). Since motor neurons do not express TrkA, this reduction could only be attributed to decreased levels of TrkB and/or TrkC.
Accordingly, a similar decrease of TrkB transcript levels was observed ( Figure S1D ).
gt/gt motor neurons were indistinguishable from their wild type counterparts, since we observed no statistically significant difference in terms of either the abundance of synaptic boutons ( Figure S2B-C) , or the morphology of the neurite network ( Figure   S2D -G). Taken together, these results demonstrated that RRP227 gene trap ES cellderived motor neurons were a suitable model system with which to investigate the functional consequences of BICD1 depletion on the trafficking of neurotrophin receptors.
BICD1 depletion affects the internalisation and intracellular fate of HCT
Our siRNA screen revealed that Bicd1 knockdown increased the intracellular accumulation of HCT compared to cells transfected with control siRNA (Terenzio et al, 2014 ), a phenotype that was replicated in Bicd1 gt/gt motor neurons (Figure 2A-B) .
Overexpressing BICD1-GFP in Bicd1 gt/gt motor neurons rescued this phenotype by decreasing HCT accumulation compared to neurons expressing GFP alone ( Figure   S3A and 2C), confirming that the observed phenotype was a direct consequence of BICD1 depletion. To further investigate the nature of the intracellular compartment to which BICD1 associates, we purified a population of endosomes containing monocrystalline ion oxide nanoparticles (MION) -conjugated HCT (Deinhardt et al, 2006b; Wade et al, 2012) . Many of these organelles are signalling endosomes as they are known to contain Trk receptors and p75 NTR , and are transported from the periphery towards the motor neuron soma by cytoplasmic dynein (Schmieg et al, 2013) . BICD1 associated with this compartment together with its known interactors p150 Glued and p50, two subunits of the dynactin complex that are required for dynein motor activity, and Rab6, a small GTPase involved in Golgi to ER retrograde trafficking ( Figure S3B ) (Fuchs et al, 2005; Matanis et al, 2002) .
Because BICD1 undergoes axonal retrograde transport (Terenzio et al, 2014) and has been previously implicated in its regulation (Wanschers et al, 2007) , we tested whether this trafficking pathway was altered in Bicd1 gt/gt motor neurons. Surprisingly, there was no significant difference in the speed or frequency of axonal retrograde carriers containing αp75 NTR ( Figure S3C ) and HCT (Terenzio et al, 2014) between wild type and mutant neurons, suggesting that the increase somatic accumulation of HCT observed in motor neurons depleted of BICD1 was not due to abnormalities in axonal retrograde transport.
Alternatively, the increased accumulation of HCT found in Bicd1 gt/gt motor neurons (Figure 2A -B) might have been caused by defective endosomal sorting and/or trafficking in the cell soma. To test this possibility, we used transmission electron microscopy to trace the intracellular fate of internalised HCT conjugated to colloidal gold in wild type and Bicd1 gt/gt motor neurons, and determined the morphology of goldcontaining organelles at the ultrastructural level ( Figure 2D and Figure 4) . Some of these HCT-containing compartments resembled multi-vesicular bodies (MVBs), which was not surprising since HCT was previously reported to associate with these organelles (Parton et al, 1987) . Other HCT-containing membrane compartments were described on the basis of their contents: 'amorphous' (no clearly identifiable content and low electron density), 'membranous' (relatively high membrane content) and 'tubular', because of their characteristic morphology ( Figure 2D ). Compared to wild type cells, Bicd1 gt/gt motor neurons contained significantly more HCT in the 'amorphous' compartments where it clustered close to the limiting membrane ( Figure 2D ).
Interestingly, when compared to wild type controls, Bicd1 gt/gt motor neurons displayed an inverse relationship in the abundance of HCT-positive 'amorphous' organelles relative to MVBs ( Figure 2E) . Occasionally, HCT concentrated as clusters within budlike protrusions, which were often contiguous with the lumen of compartments with 'amorphous content' ( Figure S3D ). These structures were more commonly observed in Bicd1 gt/gt motor neurons and were believed to represent enlarged endosomal sorting compartments.
TrkB associates with enlarged endosomal compartments in Bicd1 gt/gt motor neurons Because HCT displayed an extensive colocalisation with TrkB ( Figure 3A ) and p75 NTR (Deinhardt et al, 2007; Deinhardt et al, 2006b; Lalli & Schiavo, 2002) Figure   4A with 4B), indicating that endosomal trafficking of neurotrophin receptors was also affected by BICD1 depletion.
The increased association of HCT, TrkB and p75 NTR with these compartments in Bicd1 gt/gt motor neurons suggested that BICD1 could play a role in the endocytic sorting of neurotrophin receptors and HCT in the cell body. This view was supported by the observation that HCT co-localised with components of the retromer complex, most notably sorting nexin 1 (SNX1) (Figure S4A -B) and Vps26 (Terenzio et al, 2014) . TrkB was also localised to endogenous SNX1-positive compartments ( Figure 3B-C) . We resorted to using N2A neuroblastoma cells overexpressing FLAG-tagged TrkB for this experiment because of the inability to simultaneously detect endogenous TrkB and SNX1 using antibodies raised in the same species (see Supplemental Information).
Overexpressing FLAG-TrkB in N2A cells followed by incubation with BDNF-mCherry demonstrated that endogenous BICD1 co-localised with BDNF/TrkB-positive organelles ( Figure 3D) .
Importantly, the co-distribution of HCT with SNX1-positive compartments was higher in Bicd1 gt/gt motor neurons compared to wild type cells ( Figure S4A-B We previously showed that p75 NTR undergoes rapid recycling at the plasma membrane in the absence of neurotrophins (Deinhardt et al, 2007) . This steady-state recycling of p75 NTR in the absence of exogenous ligands was unaffected by BICD1 depletion (Figure S5A-B) . To test whether BICD1 was required for the BDNF-induced trafficking of p75 NTR , we treated wild type and Bicd1 gt/gt motor neurons with exogenous BDNF, a treatment which promoted the recruitment of p75 NTR to a clathrin-dependent endocytic pathway linked to axonal retrograde transport (Deinhardt et al, 2007) . The addition of BDNF resulted in a marked increase in the intracellular accumulation of αp75 NTR , which was significantly higher in Bicd1 gt/gt motor neurons compared to wild type controls ( Figure S5C-D) , indicating that BICD1 is required for the trafficking of BDNF-bound p75 NTR , but does not influence the neurotrophin-independent trafficking of this receptor.
This effect was unlikely to have resulted from the altered axonal retrograde transport of αp75 NTR , as this process was not affected by BICD1 depletion ( Figure S3D) .
A similar ligand-dependent accumulation phenotype was also observed for TrkB in Bicd1 gt/gt motor neurons (Figure 5A-D) . Like many receptor tyrosine kinases, activated
TrkB-BDNF complexes traffic to the late endosomal pathway and are ultimately delivered to lysosomes for degradation (Chen et al, 2005) . We tested whether the increased accumulation of ligand-activated TrkB in Bicd1 gt/gt motor neurons was caused by the defective sorting of this receptor to lysosomes by inhibiting lysosomal proteases using a cocktail of well-characterised inhibitors (leupeptin, E64D and pepstatin A). Only wild type motor neurons were affected by this treatment, whereas αTrkB accumulated to similar levels in treated and untreated Bicd1 gt/gt motor neurons ( Figure S6A) . A similar trend was also established for αp75 NTR accumulation ( Figure   S6B ). We did not detect any obvious difference either in lysosomal acidification or distribution of LAMP2-positive organelles between Bicd1 gt/gt and wild type motor neurons, suggesting that BICD1 depletion does not affect lysosome biogenesis or function, but is likely to cause an impaired sorting of neurotrophin receptors along the degradative pathway. Consistent with this idea was our observation that intracellular accumulation of HCT was unaffected by lysosomal inhibitors ( Figure S6C ), which was not surprising since this probe does not enter the lumen of lysosomes ( Figure S6D) and therefore is not degraded by these organelles.
Since the results described in Figure S6A -B were obtained by an imaging approach using fluorescent αTrkB and αp75 NTR , we wanted to confirm these results using a more direct biochemical strategy. For this purpose we selected a pulse-chase protocol, which allowed us to follow the dynamics of a cohort of internalised receptors as they trafficked along the endosomal pathway. To this end, we loaded ES-derived motor neurons with a 15 min pulse of αTrkB in the presence of BDNF and lysosomal inhibitors or vehicle control, followed by 1 or 2 h incubation in the presence or absence of lysosomal inhibitors. After cell lysis, antibody pulldown followed by western blotting revealed a major band of full length TrkB (TrkB.FL; 145 kDa) and a minor band of TrkB.T1 (90 kDa), representing the truncated dominant-negative form of this receptor (Fenner, 2012) , in wild type cells (upper panel, Figure 5E ). However, samples isolated from Bicd1 gt/gt motor neurons displayed a striking increase of TrkB.T1 relative to
TrkB.FL (lower panel, Figure 5E ). In agreement with the immunofluorescence data quantified in Figure S6A , lysosomal inhibitors proved effective in preventing the degradation of aTrkB in wild type, but not in Bicd1 gt/gt motor neurons ( Figure 5E ), suggesting that BICD1 depletion impaired lysosome-mediated degradation of these receptors.
TrkA is degraded by the combined actions of lysosomes and the proteasome (Geetha & Wooten, 2008; Sommerfeld et al, 2000) , a pathway shared at least in part by TrkB (Sommerfeld et al, 2000) . Interestingly, proteasomal inhibition redirects TrkA from late endosomes to the recycling route (Moises et al, 2009 ). Therefore, the residual degradation of TrkB observed for wild type motor neurons at the latest time point ( Figure 5E , 120 min) could be the result of its clearance by the proteasome, and suggested a possible explanation for the apparent ineffectiveness of lysosomal inhibitors in preventing the clearance of TrkB from Bicd1 gt/gt motor neurons (lower panel, Figure 5E ). To test this hypothesis and assess the impact of BICD1 on these degradative pathways, we repeated the 15 min pulse step in the presence or absence of MG132, a specific proteasome inhibitor. Probing the αTrkB immunoprecipitates with the TrkB antibody revealed profiles similar to those shown in the previous experiment (compare upper panels in Figure 5F with 5E). However, re-probing the same membrane with an ubiquitin-specific antibody revealed a signal only for the Bicd1 gt/gt sample treated with a combination of lysosomal inhibitors and MG132 ( Figure 5F ).
This result implied that within 15 min of exposure to BDNF, TrkB internalised by
Bicd1 gt/gt motor neurons was preferentially ubiquitinated and likely targeted for proteasome-mediated degradation.
BICD1 depletion increases neurotrophin receptor levels at the plasma membrane
Inhibition of the proteasome, which causes an accumulation of ubiquitinated Trks, redirects TrkA from late endosomes to a plasma membrane recycling pathway ( 
TrkB signalling is impaired in Bicd1 gt/gt motor neurons
The most striking finding from the previous set of experiments was the substantial increase in TrkB.T1 localisation to the surface of Bicd1 gt/gt motor neurons (Figure 5E-F and 6C-E). TrkB.T1 heterodimerise with TrkB.FL to inhibit auto-phosphorylation and downstream signalling of the full length receptor (Eide et al, 1996; Fenner, 2012) .
Therefore, the substantially decreased ratio of TrkB.FL to TrkB.T1 ( Figure 6E ) on the plasma membrane of Bicd1 gt/gt motor neurons, together with an increased cell surface localisation of p75 NTR ( Figure S7A-D) , would be expected to reduce phosphoinositide-3 kinase (PI3K) and Ras-mediated signal activation following treatment with BDNF.
To test this hypothesis, we stimulated motor neurons with BDNF for various time points before assaying lysates by western blotting for phosphorylated TrkB, AKT and ERK1/2.
In wild type cultures, both AKT and ERK1/2 phosphorylation peaked at 10 min followed by a progressive attenuation of this response over the following 40 min. The same overall trend was observed for Bicd1 gt/gt motor neurons, but phosphorylation of both AKT and ERK1/2 was lower at all time points tested ( Figure 7A-D Figure 7E -F, where phosphorylation of TrkB upon stimulation with BDNF for 10 min was lower in mutant motor neurons compared to wild type controls.
Proteosomal inhibition is known to induce sustained ERK1/2 activation following NGF stimulation (Moises et al, 2009) , which was likely to result from enhanced TrkA recycling back to the plasma membrane. We have now shown that Bicd1 gt/gt motor neurons respond to BDNF/TrkB activation through sustained PI3K/AKT signalling.
Thus, whereas the phospho-AKT profile tailed off at later time points in wild type cells, BICD1-depleted motor neurons displayed a more prolonged AKT activation during 1 h of BDNF stimulation ( Figure 7A-B) . This trend was substantiated by prolonged stimulation experiments when phospho-AKT levels, albeit lower, remained relatively stable over the entire time-frame of the experiment in Bicd1 gt/gt motor neurons ( Figure   7G ).
Discussion
Using a novel siRNA screening approach designed to identify new players involved in the trafficking of neurotrophin receptors and neurotropic virulence factors in motor neurons (Terenzio et al, 2014) , we have identified several genes that affected the intracellular accumulation of HCT and αp75 NTR . Because of our long standing interest in axonal retrograde transport, the most intriguing candidate revealed by this screen was
Bicd1. This cytoplasmic dynein adaptor and closely related proteins, such as BICD2
and BICDR1, play diverse roles in nervous system development and maintenance (Matanis et al, 2002; Schlager et al, 2010) . For instance, BICD2 is required for neuronal migration (Jaarsma et al, 2014) , whereas BICD1 cooperates with dynein and kinesins in C. elegans nervous system patterning (Aguirre- Chen et al, 2011) .
Furthermore, Drosophila BicD recycles clathrin heavy chain back to the plasma membrane during synaptic stimulation (Li et al, 2010) , and controls distribution of Fragile X mental retardation protein (Bianco et al, 2010) . Our in vivo observations now expand this list of functions by showing that BICD1 very likely plays an important role in the developing mouse nervous system, at least during the period when BDNF and neurotrophin receptors are highly expressed (Figure 1 and S1).
Silencing of Bicd1 increased the intracellular accumulation of HCT and this was confirmed in motor neurons expressing the RRP227 Bicd1 gt/gt hypomorphic allele. The intracellular distribution of HCT in Bicd1 gt/gt motor neurons differed markedly from that observed in wild type cells (Figure 2D-E) . In mutant cells, HCT clustered near the limiting membrane of a population of enlarged organelles with amorphous content, which lacked intra-luminal vesicles typical of MVBs ( Figure 2D ) and was found in protrusions emanating from such structures ( Figure S3D ). These observations suggested that endosomal sorting and/or maturation of these HCT-containing compartments were perturbed in Bicd1 gt/gt motor neurons. Because HCT is cotransported with p75 NTR and TrkB, we inferred that these receptors were also likely to be present in at least a sub-population of the enlarged HCT-labelled compartments present in Bicd1 gt/gt motor neurons. This conclusion was supported by the findings that colloidal gold-labelled HCT, αTrkB and αp75 NTR all accumulated in the same enlarged organelles (Figure 4) , which strongly suggested that these structures represented sorting compartments common to all three probes. Furthermore, the increased occurrence of such organelles in Bicd1 gt/gt motor neurons indicated that BICD1 depletion affected the endosomal sorting of HCT, TrkB and p75 NTR .
This hypothesis was supported by the observation that HCT-positive organelles in Bicd1 gt/gt motor neurons also displayed an increased co-localisation with SNX1, a retromer component (Figure S4A-B) . Retromer is a large protein complex, which controls the endosome membrane re-sculpturing process essential for the formation of transport carriers (Bonifacino & Hurley, 2008; Cullen & Korswagen, 2012 ) and the selection of specific cargoes (Harrison et al, 2014) . Classically, this complex has been shown to mediate retrograde transport of cargoes from endosomes to the trans-Golgi network (TGN). However, Steinberg et al. have recently shown that the retromer and specific SNX isoforms, such as SNX17 and SNX27, were involved in preventing lysosomal degradation in favour of maintaining plasma membrane levels of several transporters, signalling receptors and adaptor molecules, such as the glucose transporter GLUT1, PDGFRβ and the neurotrophin receptor binding protein Kidins220/ARMS (Steinberg et al, 2013; Steinberg et al, 2012) . Moreover, retromerindependent functions for SNX1 in the recycling of specific receptors to the plasma membrane have also been described (Nisar et al, 2010) . The retrograde pathway to the TGN is unlikely to be involved in the re-routing of HCT and neurotrophin receptors when BICD1 is depleted, since cholera toxin B subunit (CTB) trafficking to the Golgi was unaffected in Bicd1 gt/gt motor neurons ( Figure S8) . Importantly, this result also demonstrated that the depletion of BICD1 did not cause a general defect in endosomal trafficking.
Similar increased accumulation phenotypes in Bicd1 gt/gt motor neurons were also observed for p75 NTR and TrkB, but only after treatment with BDNF ( Figure 5A -D and
S5A-D).
Upon stimulation, phosphorylated TrkB is mainly sorted to lysosomes and degraded (Bronfman et al, 2007; Chen et al, 2005; Huang et al, 2009 Figure S6A-B) . These data, together with the lack of overt alterations in lysosome morphology and activity in Bicd1 gt/gt motor neurons, implied that BICD1 is not likely to be involved in lysosome biogenesis or function, but participates in a sorting step regulating the targeting of endocytic cargoes to these organelles (Figure 8) . TrkB antibody feeding assays confirmed this view by demonstrating that upon treatment with BDNF, TrkB internalised by Bicd1 gt/gt motor neurons was not protected from degradation in the presence of lysosome protease inhibitors ( Figure 5E ). This result suggested that TrkB-BDNF complexes were preferentially degraded by an alternative mechanism in these cells. This was likely to be via the proteasome since ubiquitinated TrkB was only detected in immunoprecipitates retrieved from Bicd1 gt/gt motor neurons in which proteasomal activity was inhibited ( Figure 5F ). Trk receptors have been shown to be ubiquitinated and a proportion of this modified receptor pool is degraded by the proteasome (Geetha & Wooten, 2008; Sommerfeld et al, 2000) . This posttranslational modification is important for neurotrophin receptor function since defective ubiquitination of TrkA causes defective endosomal trafficking, impaired degradation and increased recycling of this receptor, which was proposed to lead to the increased survival of sensory neurons in vivo (Yu et al, 2014) . Our findings now suggest that BICD1 plays a role in this pathway by regulating the balance between these two degradation fates. We speculate that impaired targeting of TrkB to lysosomes in neurons lacking BICD1 might cause an increased ubiquitination and re-routing of this receptor to the proteasome and the recycling pathway, resulting in the increased targeting of TrkB and p75 NTR to the plasma membrane, possibly via a SNX/retromermediated retrieval route (Figure 8) . Such a mechanism would be expected to ensure appropriate TrkB-mediated signalling output in response to BDNF availability and according to the composition of receptor complexes bound to this ligand.
Several lines of evidence indicate that impairments of the trafficking and/or degradation of neurotrophin receptors alter the output of neurotrophin signalling cascades (Ascano et al, 2012; Reichardt, 2006) . For example, overexpression of Hrs, a component of the endosomal sorting complex required for transport (ESCRT), in PC12 cells caused a redirection of TrkB to the recycling route and a more sustained ERK1/2 activation upon BDNF treatment (Huang et al, 2009) . Similar behaviour has also been described for
TrkA in the same cell line, where inhibition of endosomal maturation by overexpression of a dominant-negative Rab7 mutant resulted in the accumulation of TrkA-containing endosomes and an increased ERK1/2 signalling (Saxena et al, 2005) . Furthermore, proteosomal inhibition induced a sustained NGF-dependent ERK1/2 activation (Moises et al, 2009 ). Based on these results, we investigated the signalling response to BDNF in Bicd1 gt/gt motor neurons and found that TrkB phosphorylation and the downstream activation of PI3K-AKT and Ras-ERK1/2 were decreased in Bicd1 gt/gt motor neurons (Figure 7) . Notably, AKT phosphorylation levels, albeit lower, remain stable over a longer period in Bicd1 gt/gt motor neurons compared to wild type cells (Figure 7G ), supporting the notion that receptor recycling is an important mechanism to sustain signalling by rapidly returning growth factor receptors to the plasma membrane (Chen et al, 2005; Huang et al, 2013 TrkB isoforms in order to protect themselves from chronic TrkB.FL-mediated overstimulation, which is in agreement with the neuronal response to excitotoxic insult during brain ischemia and traumatic brain injury (Gomes et al, 2012 ).
In conclusion, we would like to propose a model by which BICD1 controls the trafficking of activated neurotrophin receptors to appropriate degradation routes to maintain an optimal response to neurotrophin stimulation. By impinging on this trophic response, BICD1 functions to modulate the signalling amplitude and duration elicited by ligandbound neurotrophin receptors. In this context, BICD1 serves to fine tune neurotrophin receptor signalling by maintaining the balance between receptor degradation over recycling so that the remaining receptor pool not destined for degradation is targeted back to the plasma membrane by a retromer-mediated sorting process ( Figure S8 ).
This equilibrium ensures optimal signal intensity and/or duration by delivering the appropriate repertoire of neurotrophin receptors to the plasma membrane where they are available to respond to their cognate ligands, which are especially abundant during neuronal growth. BICD1 function would therefore be expected to be critical during nervous system development when neurons rely on neurotrophins for their specification, differentiation and survival. Indeed, this may be one reason why BICD1 is highly expressed together with neurotrophins and their receptors in the developing nervous system (Figure 1 and S1) . TrkB-BDNF signalling mechanisms are instrumental in regulating nervous system development and are key modulators of synaptic plasticity in adulthood. Intriguingly, dendritic elongation and branching of cortical neurons is controlled by the differential activation of TrkB.FL versus TrkB.T1 (Yacoubian & Lo, 2000) , whilst p75 NTR is a negative modulator of dendrite complexity in hippocampal neurons (Zagrebelsky et al, 2005) . These functions are very likely to operate in concert with BICD1, which was recently shown to be essential for the correct neuronal patterning and dendritic branching in C. elegans (Aguirre- Chen et al, 2011) .
These studies and our current work collectively indicate that BICD1 helps to coordinate the complex membrane sorting of neurotrophin signalling endosomes during nervous system development, and may regulate the activity of other receptor tyrosine kinases in different cell types.
Materials and Methods
Ethics statement
All experiments were carried out following the guidelines of the Cancer Research UK genetic manipulation procedures. Animal work was carried out under licence from the UK Home Office in accordance with the Animals (Scientific Procedures) Act 1986.
Reagents
Unless otherwise stated, all chemical reagents were supplied by Sigma. Tissue culture media, supplements and AlexaFluor555-conjugated cholera toxin B subunit (CTB) and secondary antibodies were purchased from Life Technologies.
Antibodies
Actin ( mouse monoclonals to p150 Glued and p50 from BD Biosciences. αp75 NTR (5410) was described in (Deinhardt et al, 2007) . SNX1 and Vps26 antibodies were a kind gift of Matthew Seaman, University of Cambridge.
BDNF-mCherry expression
A BDNF-mCherry expression construct was kindly provided by F. Saudou (Institut Curie, Orsay, F) (Gauthier et al, 2004 ) and transfected using Lipofectamine 2000 (Life Technologies) into HEK293-FT cells, which had previously been adapted to grow in suspension in HyClone Serum-Free Medium (SFM; Thermo Scientific). SFM conditioned with secreted BDNF-mCherry was collected after 72 h, centrifuged at high speed and the supernatant concentrated approximately 15 fold by force filtration using Amicon Ultra Centrifugal filters (Ultracel 30K; Millipore). The concentrate was snap frozen at -80˚C and then analysed by western blotting against recombinant BDNF (R&D Systems) to assess BDNF-mCherry concentration (Deinhardt et al, 2006b) before performing FLAG-TrkB internalisation experiments in N2A cells.
Bicd1 gt/+ chimeric embryos and lacZ expression analysis
10-15 RRP227 ES cells were injected into blastocyst stage embryos collected from superovulated C57BL/6J female mice that had been mated to C57BL/6J male mice.
Embryos were transferred to pseudo-pregnant (2.5 days post coitum) recipient mice according to standard protocols (Nagy et al, 2002 
ES cell-derived motor neurons
ES cells were grown on fish skin gelatin coated flasks in Glasgow Minimal Essential Medium (GMEM), 5% ES cell-qualified foetal bovine serum FBS, 5% knockout serum replacement (KSR), 1% GLUTAMAX, 0.1 mM 2-mercaptoethanol and 1,000 units/ml of leukaemia inhibitory factor (ESGRO, Millipore). To generate motor neurons, 1.5 x 10 6 ES cells were grown in suspension on a 10 cm non-tissue culture treated Petri dish containing differentiation (DFNK) medium: 45% Neurobasal, 45% DMEM/Ham's-F12, 10% KSR, 1% GLUTAMAX and 0.1 mM 2-mercaptoethanol. The following day, EBs were gently centrifuged and re-suspended in 10 ml of fresh DFNK medium and plated on a new Petri dish. The following day, the greatly enlarged EBs were allowed to sediment by gravity and re-suspended in fresh DFNK medium supplemented with 1 µM all-trans retinoic acid (RA) and 333 nM Smoothened Agonist (SAG; Enzo Life Sciences). EBs were maintained under these conditions for a further 4 days (medium changed every other day) and then dissociated with 0.025% porcine pancreatic trypsin in 1 ml PBS for 7 min at 37˚C and processed as described previously for the dissociation of mouse E13.5 spinal cord motor neurons (Hafezparast et al, 2003) . Cells were plated onto poly-D-ornithine and laminin coated dishes in motor neuron growth medium: Neurobasal medium supplemented with 2% B27, 2% heat-inactivated horse serum, 1% GLUTAMAX, 25 µM 2-mercaptoethanol, 10 ng/ml rat ciliary neurotrophic factor (CNTF; R&D Systems), 100 pg/ml rat glial cell line-derived neurotrophic factor (GDNF; R&D Systems) and 1 µM RA.
Generation of homozygous RRP227 ES cells
Mouse ES cells with a gene-trap insertion in the first intron of Bicd1 (RRP227;
http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=alleleDetailandkey=5448 86) were obtained from the Mutant Mouse Regional Resource Center. Homozygous Bicd1 gt/gt cells were generated as previously described (Lefebvre et al, 2001) . Briefly, heterozygous cells were seeded at 30% confluence and maintained under standard feeder-free ES cell culture conditions in medium containing 1.5 mg/ml G418 until distinct clones of antibiotic-resistant cells appeared. Several clones were picked up into a drop of 0.025% trypsin solution and seeded into separate wells of a 24-well plate and grown in the presence of 500 ng/ml G418. Loss of heterozygosity was assessed by semi-quantitative real time PCR using the One-Step RT-PCR kit (Life Technologies) and primers specific for the wild type Bicd1 cDNA (forward: ggc tgg tgg tgc tgg agg aga a; reverse: gtg gac act agt ttc tgc aat gtg a).
The G418-resistant ES cell clone that showed the most marked reduction in PCR product relative to the heterozygous parent cell line was then selected for further quantification by quantitative real time PCR (Table S2) , which confirmed an approximately 70% reduction in Bicd1 expression relative to wild type ES cells.
Quantitative real time-PCR
Total RNA was extracted from ES cell-derived motor neuron cultures 4-5 days after the plating of disaggregated embryoid bodies (EBs), using either Trizol (Life Technologies) or RNeasy kits (Qiagen). 1-2 µg of total RNA was used to synthesise cDNA using the Superscript-VILO cDNA synthesis kit (Life Technologies), cDNA was diluted 1/10 and PCR amplified on a 7500 Fast Real Time PCR (Applied Biosystems) using intron spanning primers (Table S2 ) and EXPRESS SYBR Green ER master mix (Life Technologies).
Immunofluorescence and immunohistochemistry
Motor neurons were seeded onto poly-D-ornithine and laminin-coated coverslips, 
Internalisation assays
Cell surface biotinylation
The pool of neurotrophin receptors on the plasma membrane was quantified using a cell surface biotinylation kit (Thermo Scientific) according to the manufacturer's instructions. Briefly, wild type and Bicd1 gt/gt motor neurons were assayed under steady state conditions 4-5 d after plating at high density onto 6 cm dishes, by cooling on wet ice before removing the growth medium, washing with ice-cold PBS and crosslinking cell surface exposed proteins with sulfo-NHS-SS-biotin for 30 min on ice. After quenching, cells were scraped, pelleted, washed twice with ice cold Tris-buffered saline (TBS) and lysed on ice for 30 min. Insoluble proteins were pelleted by centrifugation and supernatants adjusted to the same protein concentration.
Biotinylated proteins from 100 μg of total lysate were isolated with neutravidin agarose beads prior to western blot analysis.
Endosome isolation and western blotting
MION-conjugated HCT was used to purify HCT-positive endosomes, which were isolated as previously described (Wade et al, 2012) . SDS-PAGE was performed using 4-12% NuPAGE Bis-Tris gradient gels (Life Technologies) according to the manufacturer's instructions and blotted onto polyvinylidene fluoride (PVDF) membranes. Membranes were blocked in 5% skimmed milk or 5% BSA dissolved in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 h at room temperature and then incubated with primary antibodies diluted 1:1,000 or 1:2,000 in TBST for 1 h at room temperature or overnight at 4˚C. Blots were then washed and incubated with appropriate HRP-conjugated secondary antibodies (GE Healthcare). Immunoreactivity was detected using Luminata or Crescendo ECL substrates (Millipore) and ECLHyperfilm (GE-Healthcare).
Pharmacological experiments
HCT and ap75 NTR and αTrkB internalisation/accumulation assays were performed as described in the main text, but in the presence of lysosomal inhibitors (leupeptin 200 μM, E64D 2 μM, pepstatin A 20 μM) or an equivalent volume of DMSO. Cells were allowed to internalise the probes for 1 h at 37°C, acid-washed for 2 min, washed in PBS and fixed with 4% PFA for 20 min. To detect internalised αp75 NTR or αTrkB the cells were immunostained with anti-rabbit AlexaFluor555-conjugated IgG.
For biochemical assessments of internalised receptor fate, a pulse-chase antibody feeding assay was performed as follows: motor neuron cultures were incubated with αTrkB and BDNF in the presence or absence of lysosomal inhibitors in complete growth medium as described above, but instead of a 1 h continuous feed, a 15 min internalisation pulse was performed. This was followed by washing the cells three times with fresh antibody-free medium and incubation for a further 1 or 2 h as above, but in the absence of αTrkB. To assess TrkB ubiquitination the same protocol was used with the addition of MG132 (10 µM), which was present throughout the pulse and chase periods. The quantity of initially internalised αTrkB/TrkB complex (15 min pulse) and non-degraded αTrkB/TrkB remaining after the chase periods was determined by immunoprecipitating the antibody/receptor complex from cell lysates prepared as described for the signalling assay in the main text. Lysates were then incubated for 1 h at 4˚C with 10 µl of pre-washed Protein-G coated Dynabeads (Life Technologies) per sample. TrkB bound beads were then washed three times in lysis buffer followed by SDS-PAGE and western blotting. The top half of these blots was first probed using the rabbit anti-TrkB (80E3) antibody. Some blots were then stripped and re-probed for ubiquitin using the mouse FK2 antibody. The lower half of these same blots were probed separately with HRP-conjugated anti-rabbit immunoglobulins in order to detect internalised αTrkB.
CTB accumulation assay
Wild type and Bicd1 gt/gt motor neurons were allowed to internalise AlexaFluor555-CTB
(1 µg/ml) for 1 h at 37°C, acid-washed for 2 min, washed in PBS and fixed with 4%
PFA for 20 min. Samples were immunostained for bIII tubulin and imaged. The amount of CTB accumulation in the Golgi area was quantified using ImageJ.
Neurite outgrowth assay
Wild type and Bicd1 gt/gt motor neurons were plated at equal density, fixed 48 h after plating with 4% PFA for 20 min, immunostained for bIII tubulin and imaged.
Quantification of total outgrowth, maximum process length and number of branches was performed using Metamorph (Molecular Devices).
Signalling assays
Wild type and Bicd1 gt/gt motor neurons were starved for 5 h at 37˚C in Neurobasal medium and then stimulated with 100 ng/ml of BDNF in same medium. At the appropriate time points, cells were placed on ice immediately after removing the growth medium and then lysed in 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 1 mM EDTA containing HALT protease and phosphatase inhibitors (Thermo Scientific) for 30 min. Insoluble proteins were pelleted and protein concentration assayed in the supernatants before addition of sample buffer. Samples were heated for 10 min at 70˚C and 5-15 µg of protein per sample loaded in SDS-PAGE prior to western blotting for phospho-TrkB, phospho-AKT and phospho-ERK1/2. Phosphorylation levels were quantified either by re-probing the same membranes, or in some cases by running the same lysates in parallel and immunoblotting for the respective total proteins.
Axonal retrograde transport assay
Axonal retrograde transport kinetics of HCT and αp75 NTR in wild type and in Bicd1 gt/gt motor neurons was performed as previously described (Deinhardt et al, 2006b; Lalli & Schiavo, 2002) and quantified using Motion Analysis software (Kinetic Imaging) (Bohnert & Schiavo, 2005; Deinhardt et al, 2006b ).
BICD-GFP and FLAG-TrkB overexpression in N2A cells
N2A cells were transfected with FLAG-TrkB constructs (kindly provided by Francis Lee, Weill Cornell Medical College, NY) and BICD1-GFP using Lipofectamine2000 according to the manufacture's instructions. Approximately 13 h after transfection, antibody uptake experiments were performed on N2A cells by incubation with FLAGtag antibody (clone M1, 1:1000) in the presence either of recombinant BDNF (100 ng/ml) or purified mCherry-BDNF for 1 h at 37°C. Cells were then acid-washed for 2 min, washed in PBS and fixed with 4% PFA for 20 min. Cells were then immunostained with AlexaFluor555-or AlexaFluor488-conjugated anti-mouse antibodies to detect internalised FLAG-TrkB and primary antibodies targeting endogenous SNX1 or BICD1.
Transmission electron microscopy
HCT was conjugated to colloidal gold by mixing 250 µg of purified HCT in 0.5 ml of 2 mM sodium tetraborate to 1 ml of colloidal gold particles (10 nm; British Biocell) previously adjusted to pH 6.0. αp75 NTR (#5411; 200 µg in 0.2 m ) and αTrkB (#07-225; 60 µg in 200 µ ) were dialysed against 2 mM sodium tetraborate and incubated with 2 ml (5 nm) and 0.2 ml (20 nm), respectively, of colloidal gold previously adjusted to pH 9.0. Samples were stirred at room temperature for 10 min. BSA was added to a final concentration of 1% and the mixture stirred for a further 10 min. The suspension was finally pelleted at 45,000g for 45 min (αp75 NTR ), 30 min (HCT) and 10 min (αTrkB), resuspended in the original volume of 20 mM Tris-NaOH pH 8.2, 150 mM NaCl, 1%
BSA and stored at 4˚C for a maximum of 2-3 weeks.
Motor neurons plated on coverslips were incubated with 20 nM nanogold-conjugated HCT for 2 h at 37˚C prior to washing. Cells were fixed in 2.5% glutaraldehyde, 4%
paraformaldehyde in Sorensen's phosphate buffer at room temperature for 20 min, post-fixed in osmium tetroxide, stained with tannic acid and dehydrated progressively up to 100% ethanol. Finally, coverslips were embedded in an Epon epoxy resin, sectioned (70-75 nm) and stained with lead citrate. Images were acquired using a Tecnai Spirit Biotwin (FEI) transmission electron microscope. Random grids were visually scanned for the presence of nanogold-containing organelles by two independent operators and classified as described in the main text.
Data quantification
ImageJ was used for the quantification of western blots and immunofluorescence staining in all experiments. ImageJ was used to threshold the fluorescence staining of interest and quantify the thresholded voxels. Immunostaining for neuronal-specific proteins, such as βΙΙΙ tubulin, was used as object masks to quantify both immunostaining intensity as well as fluorescent probe binding and internalisation.
Supplementary data
Supplementary Tables and Figures are Quantification of internalised αTrkB from three independent experiments is shown in B (n=3, t-test, mean ± s.e.m., n.s., not significant).
(C, D) Internalisation of αTrkB as described for (A), but stimulated with 100 ng/ml of BDNF. Scale bar = 20 μm. Quantification of internalised αTrkB in the presence of BDNF from three independent experiments is shown in D (n=3, t-test, ± mean ± s.e.m., **, p < 0.01). (A, B) Wild type and Bicd1 gt/gt motor neurons were fixed and immunostained without permeabilisation to detect cell surface exposed TrkB using the TrkB antibody used in (C) The same blot shown in (A) was probed for phospho-ERK1/2 (pERK1/2) and then re-probed for total ERK1/2.
(D) Densitometric analysis of pERK1/2 from three independent experiments including the one shown in (C). pERK1/2 band densities were normalised to total ERK (pERK/ERK) for each time point and plotted as the mean ± s.e.m. Reduced phosphorylation of ERK1/2 in Bicd1 gt/gt motor neurons compared to wild type controls was statistically significant at all time points (two ways ANOVA, p < 0.0001).
(E, F) Starved wild type and Bicd1 gt/gt motor neurons were stimulated with 100 ng/ml BDNF for 10 min before cell lysis. Samples were immunoblotted for phospho-TrkB (pTrkB; top panel), phospho-AKT (pAKT; S473; middle panels) and pERK1/2 (lower panels) (E). The same lysates were probed for total TrkB, AKT and ERK1/2 to assess loading parity between samples (F).
(G) Starved wild type (left panels) and Bicd1 gt/gt motor neurons (right panels) were stimulated with 100 ng/ml BDNF for different time points before cell lysis. Samples were immunoblotted for phospho-AKT (pAKT; S473) and total AKT. Note that there was a gradual decrease in pAKT signal over time for wild type cells, which contrasted with sustained pAKT levels for Bicd1 gt/gt motor neurons. 
